PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩130 per share · Prices as of the 2026-10-02 close
MSC Co., Ltd. is a food additive specialty maker centered on seasoning products and carrageenan, with both revenue and operating profit rising through 2025 and the margin recovery continuing into the first half of 2026.
2025 consolidated revenue reached KRW 197.7 billion with operating profit of KRW 29.7 billion (15.0% margin), marking three consecutive years of margin improvement.
The operating margin climbed to 20.7% in Q2 2026, the highest level among the most recent five quarters.
A KRW 136 billion new plant is under construction in Yangsan, targeting the health functional food, HMR, vegan, and halal markets.
Operating cash flow turned from negative in 2022 to positive in each of 2023 through 2025, improving financial stability.
Expanding K-food exports and the US/European preference shift toward natural colorants are creating a favorable industry backdrop for carrageenan and natural color demand.
MSC Co., Ltd. was founded in 1974 to supply novel food additive materials and has since expanded into the broader food business.
Its product lineup consists of processed seasoning products, carrageenan and other marine gel-based products, natural food coloring, and beverage/PET products, with seasoning and carrageenan forming the largest share of sales.
Seasoning products serve as flavor enhancers for processed foods, while carrageenan is used as a gelling and emulsion-stabilizing agent in sausages, jellies, and similar products.
The company operates subsidiaries MSC Myanmar and Shanghai Aimeixi Food Trading Co. to secure seaweed-based raw materials and support production and distribution in China.
Its affiliates include Miryang Agar, known as the largest agar producer in Asia, Myeongsin Fertilizer, which utilizes production byproducts, and Genfood, which makes sauces, beverages, and health foods, forming a vertically integrated structure spanning raw materials, processing, and byproduct utilization.
Miryang Agar produces roughly 300 tons of natural agar annually and exports a substantial portion, mainly to Japan, positioning it as Asia's largest agar manufacturer. The customer base is centered on B2B transactions with domestic processed food makers, with exports also reaching the United States, Japan, and Europe.
All products carry HACCP certification and FSSC 22000 accreditation, and halal certification provides a foothold for expansion into Middle Eastern and Southeast Asian markets.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩50.8B | ₩9.2B | 18.1% |
| 2025Q3 | ₩51.8B | ₩7.2B | 13.9% |
| 2025Q4 | ₩46.8B | ₩5.1B | 10.9% |
| 2026Q1 | ₩48.2B | ₩8B | 16.7% |
| 2026Q2 | ₩56.3B | ₩11.7B | 20.7% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2022 | ₩204.3B | ₩24.7B | ₩18.1B | 12.1% | 13.6% | 59.4% |
| 2023 | ₩189B | ₩23.7B | ₩18.5B | 12.5% | 12.3% | 48.6% |
| 2024 | ₩189.8B | ₩27.5B | ₩21.8B | 14.5% | 12.8% | 53.0% |
| 2025 | ₩197.7B | ₩29.7B | ₩23B | 15.0% | 12.2% | 46.5% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-23
Consolidated revenue in 2025 reached KRW 197.66 billion, up from KRW 189.76 billion in 2024, while operating profit rose to KRW 29.65 billion, lifting the operating margin to 15.0%. This extends a margin improvement trend that ran from 12.1% in 2022, to 12.5% in 2023, to 14.5% in 2024.
Net income attributable to owners also rose for four consecutive years, from KRW 18.1 billion in 2022 to KRW 18.5 billion in 2023, KRW 21.8 billion in 2024, and KRW 23.0 billion in 2025.
Notably, in 2023 revenue fell to KRW 189.0 billion from KRW 204.3 billion the prior year, yet net income still increased, indicating cost management helped defend profitability.
On a quarterly basis, the operating margin declined from 18.1% in Q2 2025 to 13.9% in Q3 and 10.9% in Q4, before rebounding to 16.7% in Q1 2026 and 20.7% in Q2 2026.
The margin softness in Q1 2026 appears to have been partly affected by a one-off cost increase, while Q2 2026 posted revenue of KRW 56.26 billion and operating profit of KRW 11.66 billion, the strongest margin among the most recent five quarters.
On the cash flow side, operating cash flow was negative KRW 7.76 billion in 2022 before turning consistently positive at KRW 24.2 billion in 2023, KRW 33.5 billion in 2024, and KRW 28.2 billion in 2025.
The debt ratio moved from 59.4% in 2022 to 48.6% in 2023, 53.0% in 2024, and 46.5% in 2025, showing an overall improving trend despite some fluctuation.
The food additive industry operates on a B2B structure tied to the production volumes of downstream food makers, characterized by steady, gradual growth rather than rapid expansion.
In recent periods, growing K-food exports of ramen and sauces have emerged as a structural factor supporting domestic food additive demand. In one news report, a securities industry source stated that MSC is the No. 1 domestic food additive company handling nearly every category of food additive.
There is also a view that tightening regulation of artificial colorants and additives in the United States and Europe could support demand for natural color and natural material substitutes, though this is a point-in-time observation and the pace of regulation varies by region.
Miryang Agar is described as producing roughly 300 tons of natural agar annually and exporting more than 80% of it, mainly to Japan, making it Asia's largest agar manufacturer, and in seaweed-derived materials such as carrageenan and agar, only a small number of domestic firms have mass-production capability, making it a relatively less crowded niche.
In contrast, more generic categories like seasoning and natural coloring face competition from larger food and materials companies.
New categories such as health functional foods, HMR, vegan, and halal offer growth potential but remain at an early stage of penetration, meaning it will take time before they contribute meaningfully to revenue.
The company signed a KRW 136 billion investment agreement with Yangsan city in Gyeongsangnam Province in October 2023, stating it would invest KRW 136 billion to build a new plant in the Sobuk-myeon Sotori area by 2027 and hire 60 new employees, in order to capture steady growth in the health functional food and HMR markets and create new demand by entering the vegan and halal markets.
Recent disclosures confirm this is progressing, noting that construction of a new plant targeting the health functional food and HMR markets has begun in Yangsan, Gyeongsangnam Province, with the company focusing on entry into vegan and halal markets and natural material R&D.
If the new plant proceeds as planned, it could expand production capacity and create new revenue streams, though the period leading up to completion and operation around 2027 involves upfront investment burden.
First-half 2026 results showed a marked improvement in both revenue and operating profit from Q1 to Q2, and whether this momentum continues into the second half is the next thing to watch.
The company has not publicly disclosed specific quantitative revenue or profit guidance, so future performance will need to be confirmed through quarterly disclosures.
The structure involves a favorable industry backdrop of K-food export growth and rising natural material demand, operating alongside the ever-present variables of raw material and foreign exchange volatility.
The current share price trades below the level implied by net asset value per share, suggesting the market is applying a discount relative to book value.
Net income has risen every year since 2022 and the earnings recovery has continued into the first half of 2026, so valuation metrics are in a range that partly reflects this profitability improvement.
On the dividend side, the company has paid a cash dividend every year, though its dividend policy appears to have remained relatively conservative relative to the pace of net income growth.
Given the stock's small-cap characteristics, valuation metrics can also be more volatile depending on trading volume and supply-demand conditions, which is worth keeping in mind.
These metrics reflect both business fundamentals and market supply-demand and sentiment simultaneously, an area better confirmed through future earnings disclosures than through a definitive directional call.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-23
The operating margin steadily rose from 12.1% in 2022 to 15.0% in 2025, and climbed further to 20.7% in Q2 2026, marking the highest level among recent quarters. Even in 2023, when revenue stagnated or slightly declined, net income actually increased, demonstrating strong cost management capability.
Operating cash flow has also remained in surplus every year since 2023, supporting the company's ability to convert profits into cash.
The company signed a KRW 136 billion investment agreement with Yangsan City, Gyeongsangnam-do, and construction of a new business site targeting the health functional food, HMR, vegan, and halal markets is underway.
Around the completion timeline of 2027, expanded production capacity and new revenue sources are expected. However, since the investment scale is substantial relative to shareholders' equity, continuous monitoring of the funding and execution plan progress is necessary.
The expansion of K-food exports such as ramen and sauces is cited as a structural factor supporting domestic demand for food additives including seasonings and carrageenan.
The growing preference for natural colorants in the US and Europe is also mentioned as a favorable environment for companies specializing in natural materials. Raw material sourcing and production/distribution networks through overseas subsidiaries (Myanmar, China) also support this demand base.
Revenue, which was KRW 204.3 billion in 2022, declined to KRW 189.0 billion in 2023 before increasing again in 2024-2025, indicating that the growth pattern was not consistently linear year over year.
On a quarterly basis as well, Q4 2025 revenue of KRW 46.8 billion decreased from KRW 51.8 billion in the previous quarter, showing seasonal and demand fluctuations. Given the typically moderate growth pace characteristic of the food industry, a structure that allows for rapid top-line expansion is unlikely.
Price fluctuations in imported raw materials such as seaweed-based materials and cellulose can directly affect the cost structure.
Given the business structure with a high proportion of exports, the company is also exposed to foreign exchange risk, where a strong Korean won period would reduce the KRW-converted value of overseas revenue.
The profitability decline in Q1 2026 attributed to an increase in one-time costs is also an example of cost volatility.
The KRW 136 billion investment in the new Yangsan plant is substantial relative to the company's equity base, requiring the company to bear the investment burden during the period leading up to completion.
Whether actual demand will materialize in the target markets (health functional food, HMR, vegan, halal) after the new business site begins operations remains an unconfirmed variable.
As is typical for small-cap stocks, stock price volatility could increase during periods of low trading volume, which should also be taken into consideration.
Fluctuations in the international prices of seaweed-based raw materials and various chemical/additive materials can be directly reflected in the cost of goods sold.
Given the business structure with a high export proportion, there is also an impact where a strong Korean won reduces the KRW-converted value of overseas revenue. Raw material sourcing through local subsidiaries in Myanmar and China partially diversifies this risk, but does not eliminate it entirely.
The new Yangsan plant is a multi-year, large-scale investment project targeting completion in 2027, and there remains a persistent possibility of construction schedule delays or cost overruns.
Whether actual revenue will be generated as planned in the target markets of health functional food, HMR, vegan, and halal after the new business site begins operations remains unconfirmed.
The impact on the financial structure will also vary depending on the method of funding the investment (borrowing versus internal cash).
Food additives are subject to different safety standards and certification requirements by country, meaning that regulatory changes in export destination countries can alter which products can be sold or the procedures required.
The preference for natural colorants under US and European regulations could be an opportunity factor, but it may also lead to burdens from certification and conversion costs for new products.
Maintaining existing certifications such as HACCP and FSSC 22000, as well as expanding new certifications such as halal certification, also entail ongoing management costs.
Check the Q3 2026 earnings disclosure (DART) to see whether the margin recovery seen in Q2 continues.
Check for a board resolution disclosure on the annual dividend policy and any change in the payout stance.
Confirm the finalized Q4 and full-year 2026 results together with an update on the Yangsan plant's progress (construction status, capex disbursed).
Check whether the Yangsan plant reaches completion and start-up, and whether it begins contributing new revenue from the health functional food, HMR, vegan, and halal categories.
MSC is a food additive specialist company centered on seasonings and carrageenan. Its operating margin steadily improved from 12.1% in 2022 to 15.0% in 2025, and rose further to 20.7% in Q2 2026, showing a clear recent profit recovery trend.
Operating cash flow has also remained stably in surplus since 2023, reflecting improving financial soundness. At the same time, revenue growth has not been linear year over year, and profitability temporarily declined in Q1 2026 due to an increase in one-time costs, indicating quarterly volatility as well.
The KRW 136 billion new plant investment in Yangsan, Gyeongsangnam-do, has the potential to become an important growth axis for entering the health functional food, HMR, vegan, and halal markets, but the investment burden precedes the 2027 completion timeline, and whether actual demand will materialize remains unconfirmed.
The structure involves a coexistence of favorable industry conditions—expanding K-food exports and the trend toward natural materials—alongside risks from raw material and exchange rate volatility and the execution of a large-scale investment.
Going forward, it will be important to sequentially confirm the sustainability of the profit recovery and the outcome of the investment through upcoming quarterly earnings disclosures and progress on the new plant.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.